{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T08:03:48Z","timestamp":1773821028459,"version":"3.50.1"},"reference-count":42,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1016\/j.jsbmb.2010.05.005","type":"journal-article","created":{"date-parts":[[2010,5,21]],"date-time":"2010-05-21T04:49:46Z","timestamp":1274417386000},"page":"279-286","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Novel, orally active selective progesterone receptor modulator CP8947 inhibits leiomyoma cell proliferation without adversely affecting endometrium or myometrium"],"prefix":"10.1016","volume":"122","author":[{"given":"William H.","family":"Catherino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minnie","family":"Malik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Driggers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott","family":"Chappel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Segars","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Davis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsbmb.2010.05.005_bib1","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1067\/mob.2003.99","article-title":"High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence","volume":"188","author":"Day Baird","year":"2003","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.jsbmb.2010.05.005_bib2","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1159\/000084513","article-title":"Effect of leiomyomas on fertility in patients undergoing assisted reproduction","volume":"59","author":"Benecke","year":"2005","journal-title":"Gynecol. Obstet. Invest."},{"key":"10.1016\/j.jsbmb.2010.05.005_bib3","first-page":"182","article-title":"Obstetric characteristics and perinatal outcome of pregnancies with uterine leiomyomas","volume":"49","author":"Sheiner","year":"2004","journal-title":"J. Reprod. Med."},{"key":"10.1016\/j.jsbmb.2010.05.005_bib4","first-page":"431","article-title":"Self-reported heavy bleeding associated with uterine leiomyomata","volume":"101","author":"Wegienka","year":"2003","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.jsbmb.2010.05.005_bib5","first-page":"229","article-title":"Hysterectomy rates in the United States 1990\u20131997","volume":"99","author":"Farquhar","year":"2002","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.jsbmb.2010.05.005_bib6","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ogc.2005.12.009","article-title":"Uterine artery embolization as a treatment option for uterine myomas","volume":"33","author":"Marshburn","year":"2006","journal-title":"Obstet. Gynecol. Clin. North Am."},{"key":"10.1016\/j.jsbmb.2010.05.005_bib7","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.2214\/ajr.183.6.01831713","article-title":"MRI guidance of focused ultrasound therapy of uterine leiomyomas: early results","volume":"183","author":"Hindley","year":"2004","journal-title":"Am. J. Roentgenol."},{"key":"10.1016\/j.jsbmb.2010.05.005_bib8","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1080\/01443610410001685600","article-title":"Are the anticipated benefits of myomectomy achieved in women of reproductive age?","volume":"24","author":"Olufowobi","year":"2004","journal-title":"J. Obstet. Gynaecol."},{"key":"10.1016\/j.jsbmb.2010.05.005_bib9","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0015-0282(16)45789-4","article-title":"Uterine leiomyomata: etiology, symptomatology, and management","volume":"36","author":"Buttram","year":"1981","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.jsbmb.2010.05.005_bib10","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1097\/AOG.0b013e31818aa930","article-title":"Mifepristone for the treatment of uterine leiomyomas","volume":"112","author":"Carbonell Esteve","year":"2008","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.jsbmb.2010.05.005_bib11","first-page":"243","article-title":"Low-dose mifepristone for uterine leiomyomata","volume":"101","author":"Eisinger","year":"2003","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.jsbmb.2010.05.005_bib12","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jsbmb.2003.12.004","article-title":"In vitro antiprogestational\/antiglucocorticoid activity and progestin and glucocorticoid receptor binding of the putative metabolites and synthetic derivatives of CDB-2914, CDB-4124, and mifepristone","volume":"88","author":"Attardi","year":"2004","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2010.05.005_bib13","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0303-7207(01)00743-2","article-title":"CDB-4124 and its putative monodemethylated metabolite, CDB-4453, are potent antiprogestins with reduced antiglucocorticoid activity: in vitro comparison to mifepristone and CDB-2914","volume":"188","author":"Attardi","year":"2002","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.jsbmb.2010.05.005_bib14","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1097\/AOG.0b013e3181705d0e","article-title":"CDB-2914 for uterine leiomyomata treatment: a randomized controlled trial","volume":"111","author":"Levens","year":"2008","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.jsbmb.2010.05.005_bib15","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1210\/er.2005-0001","article-title":"Selective progesterone receptor modulator development and use in the treatment of leiomyomata and endometriosis","volume":"267","author":"Chwalisz","year":"2005","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.jsbmb.2010.05.005_bib16","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1093\/humrep\/dem026","article-title":"The effects of the selective progesterone receptor modulator asoprisnil on the morphology of uterus tissues after three months treatment in patients with symptomatic uterine leiomyomata","volume":"22","author":"Williams","year":"2007","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.jsbmb.2010.05.005_bib17","doi-asserted-by":"crossref","first-page":"309","DOI":"10.7164\/antibiotics.50.309","article-title":"PF1092A, B, and C, new nonsteroidal progesterone receptor ligands produced by Penicillium oblatum II","volume":"50","author":"Tabata","year":"1997","journal-title":"J. Antibiotics"},{"key":"10.1016\/j.jsbmb.2010.05.005_bib18","doi-asserted-by":"crossref","first-page":"304","DOI":"10.7164\/antibiotics.50.304","article-title":"PF1092A, B, and C, new nonsteroidal progesterone receptor ligands produced by Penicillium oblatum I","volume":"50","author":"Tabata","year":"1997","journal-title":"J. Antibiotics"},{"key":"10.1016\/j.jsbmb.2010.05.005_bib19","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1124\/jpet.104.074146","article-title":"Endocrinological properties of two novel nonsteroidal progesterone receptor modulators, CP8816 and CP8863","volume":"313","author":"Kurata","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jsbmb.2010.05.005_bib20","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0024-3205(02)01727-7","article-title":"Priming effects of novel nonsteroidal progesterone receptor modulators CP8816 and CP8863 on the development of adenomyosis in the mouse uterus","volume":"71","author":"Mori","year":"2002","journal-title":"Life Sci."},{"key":"10.1016\/j.jsbmb.2010.05.005_bib21","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/gcc.20035","article-title":"Reduced dermatopontin expression is a molecular link between uterine leiomyomas and keloids","volume":"40","author":"Catherino","year":"2004","journal-title":"Genes Chrom. Cancer"},{"key":"10.1016\/j.jsbmb.2010.05.005_bib22","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/j.1365-2265.2008.03207.x","article-title":"Retinoic acid treatment of human leiomyoma cells transformed the cell phenotype to one strongly resembling myometrial cells","volume":"69","author":"Malik","year":"2008","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.jsbmb.2010.05.005_bib23","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.fertnstert.2006.08.111","article-title":"Novel method to characterize primary cultures of leiomyoma and myometrium with the use of confirmatory biomarker gene arrays","volume":"87","author":"Malik","year":"2007","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.jsbmb.2010.05.005_bib24","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.fertnstert.2009.01.081","article-title":"Myometrial cells undergo fibrotic transformation under the influence of transforming growth factor beta-3","volume":"93","author":"Joseph","year":"2010","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.jsbmb.2010.05.005_bib25","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.fertnstert.2006.11.093","article-title":"Uterine leiomyomas express a molecular pattern that lowers retinoic acid exposure","volume":"87","author":"Catherino","year":"2007","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.jsbmb.2010.05.005_bib26","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1016\/j.fertnstert.2008.03.045","article-title":"a nutritional supplement with antineoplastic activity, enhances leiomyoma cell apoptosis and decreases fibronectin expression","volume":"91","author":"Malik","year":"2008","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.jsbmb.2010.05.005_bib27","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1210\/me.2006-0524","article-title":"A structural and in vitro characterization of asoprisnil: a selective progesterone receptor modulator","volume":"21","author":"Madauss","year":"2007","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.jsbmb.2010.05.005_bib28","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1113\/jphysiol.1934.sp003217","article-title":"The assay of progestin","volume":"83","author":"McPhail","year":"1934","journal-title":"J. Physiol."},{"key":"10.1016\/j.jsbmb.2010.05.005_bib29","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1093\/nar\/29.9.e45","article-title":"A new mathematical model for relative quantification in real-time RT-PCR","volume":"29","author":"Pfaffl","year":"2001","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jsbmb.2010.05.005_bib30","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/j.fertnstert.2004.04.030","article-title":"Comparative ultrastructure of collagen fibrils in uterine leiomyomas and normal myometrium","volume":"82","author":"Leppert","year":"2004","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.jsbmb.2010.05.005_bib31","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/S0015-0282(16)54296-4","article-title":"Treatment of uterine leiomyomata with a luteinizing hormone-releasing hormone agonist","volume":"55","author":"Nakamura","year":"1991","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.jsbmb.2010.05.005_bib32","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1093\/humrep\/13.6.1660","article-title":"Treatment of uterine leiomyomas with a slow-release formulation of the gonadotrophin releasing hormone antagonist Cetrorelix","volume":"13","author":"Felberbaum","year":"1998","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.jsbmb.2010.05.005_bib33","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S0015-0282(16)55138-3","article-title":"Efficacy of a low-dose leuprolide acetate depot in the treatment of uterine leiomyomata in Japanese women","volume":"58","author":"Watanabe","year":"1992","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.jsbmb.2010.05.005_bib34","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/BF00299002","article-title":"Effects on bone mineral density of 12-month goserelin treatment in over 40-year-old women with uterine myomas","volume":"57","author":"Bianchi","year":"1995","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.jsbmb.2010.05.005_bib35","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1159\/000052848","article-title":"Steroidal \u2018add back\u2019 therapy in patients treated with GnRH agonists","volume":"45","author":"Freundl","year":"1998","journal-title":"Gyn. Obstet. Invest."},{"key":"10.1016\/j.jsbmb.2010.05.005_bib36","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1749-6632.1977.tb29429.x","article-title":"Glucocorticoid activity of various progesterone analogs: correlation between specific binding in thymus and liver and biologic activity","volume":"286","author":"DiSorbo","year":"1977","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.jsbmb.2010.05.005_bib37","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1677\/joe.0.1320425","article-title":"The glucocorticoid antagonist mifepristone reveals abnormal regulation of the adrenocortical system in obese Zucker rats","volume":"132","author":"Pesonen","year":"1992","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.jsbmb.2010.05.005_bib38","first-page":"189","article-title":"The cytodynamics of endometrial hyperplasia and carcinoma: a review","volume":"3","author":"Ferenczy","year":"1983","journal-title":"Ann. Pathol."},{"key":"10.1016\/j.jsbmb.2010.05.005_bib39","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0015-0282(16)60135-8","article-title":"Comparison between flare up and down regulation effects of luteinizing hormone-releasing hormone agonists in an in vitro fertilization program","volume":"50","author":"Frydman","year":"1988","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.jsbmb.2010.05.005_bib40","first-page":"4177","article-title":"Development of antiestrogens and their use in breast cancer: eighth Cain Memorial award lecture","volume":"50","author":"Lerner","year":"1990","journal-title":"Cancer Res."},{"key":"10.1016\/j.jsbmb.2010.05.005_bib41","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/BF00689674","article-title":"What do we know and what don\u2019t we know about tamoxifen in the human uterus","volume":"31","author":"Friedl","year":"1994","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.jsbmb.2010.05.005_bib42","doi-asserted-by":"crossref","first-page":"35F","DOI":"10.1016\/S0002-9149(01)02221-4","article-title":"Elucidation of the molecular mechanism of action of selective estrogen receptor modulators","volume":"90","author":"McDonnell","year":"2002","journal-title":"Am. J. Cardiol."}],"container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076010002372?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076010002372?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T23:36:49Z","timestamp":1760744209000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960076010002372"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["S0960076010002372"],"URL":"https:\/\/doi.org\/10.1016\/j.jsbmb.2010.05.005","relation":{},"ISSN":["0960-0760"],"issn-type":[{"value":"0960-0760","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel, orally active selective progesterone receptor modulator CP8947 inhibits leiomyoma cell proliferation without adversely affecting endometrium or myometrium","name":"articletitle","label":"Article Title"},{"value":"The Journal of Steroid Biochemistry and Molecular Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsbmb.2010.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}